BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial
216 auth. C. Fisher, J. Dhainaut, S. Opal, J. Pribble, R. Balk, G. Slotman, T. J. Iberti, E. Rackow, M. Shapiro, R. Greenman, H. Reines, M. Shelly, B. Thompson, J. Labrecque, M. Catalano, ... W. Knaus, J. Sadoff, M. Astiz, C. Carpati, R. Bone, B. Friedman, A. J. Mure, C. Brathwaite, E. Shapiro, L. Melhorn, Robert W. Taylor, M. Keegan, Jacklyn O’Brien, R. Schein, M. Pena, Monina Wasserlouf, J. Oropello, E. Benjamin, R. Delguidice, G. Emmanuel, T. Lie, L. Anderson, J. Marshall, W. D. Majo, O. Rotstein, D. Foster, E. Abraham, H. Middleton, C. Perry, H. Levy, D. Fry, S. Simpson, R. Crowell, M. Neidhart, D. Stevens, T. Coffman, Nagraj Narasimhan, D. K. Merrick, W. Bergquist, K. Matzel, M. Huebler, G. Foulke, T. Albertson, W. Walby, R. Allen, R. Baughman, P. Hasselgren, M. Fink, F. Favorito, B. Thompson, R. Corbin, G. Y. Shellhorse, A. Frazier, S. White, C. Garrard, C. A'Court, S. Storer, D. Gervich, Debra Foshe, R. Brase, A. Bagdahn, R. Cooney, J. S. Smith, Louis F. Martin, J. Vincent, G. Friedman, G. Berlot, J. Fletcher, Mark D. Williams, T. Wright, Steven C. Johnson, Carinda Feild, K. Wolf, N. MacIntyre, H. Dubin, M. Durkin, Penelope K. Dubin, K. Staubach, A. Fein, D. Schulman, M. Niederman, D. Chalfin, P. A. Van, Leeuwen, M. Boermeester, A. J. Schneider, J. Bander, Amy Imm, G. Bernard, L. Nelson, M. Stroud, K. Safcsak, F. Cerra, J. Rindal, Henry Mann, N. Halpern, J. Silverstein, M. Alicea, W. Sibbald, Claudio M. Martin, F. Rutledge, K. Petti, J. Russell, Robert Kruger, Alana Drummond, P. Lange, T. Seifert, A. Durocher, A. Tenaillon, R. Boiteau, T. Lherm, S. Lowry, S. Coyle, P. Barie, E. DeMaria, D. Snydman, S. Schwaitzberg, S. Nasraway, J. Grindlinger, W. Summer, Benjamen de Boisblanc, M. Wahl, K. Alestig, J. Grossman, D. Maki, H. Paz, M. Weiner, D. Bihari, David Campbell, G. Bleichner, M. Dahn, M. Lange, Jesse B. Hall, A. Pohlman, R. Wenzel, M. Grosserode, M. Costigan, W. Mileski, J. Weigelt, N. Yeston, Cheryl Irizarry, J. Ross, J. Robbins, P. Nightingale, K. Owen, S. Sandstedt, S. Berg, G. Simon, M. Seneff, K. Conry, J. Zimmerman, R. Dellinger, R. F. Johnston, Patricia Allee, P. Grande, E. Myhre, J. Dhainaut, I. Hamy, J. Mira, J. Harmon, Jon C. White, L. Mckie, H. Silverman, Pamela Tuma, D. Bennett, J. Porter, M. Laurell, S. Jacobs, S. Ash, D. Stiles, M. Prior, G. Knatterud, M. Terrin, J. Kufera, Patricia Wilkens, Knut Ra, L. Monroe, C. Sprung, C. M. Hamilton, R. Matthay, W. McCabe, J. Tonascia, H. Wiedeman, J. Wittes, G. Campion, C. R. Croft, Richard Lustick, J. Lookabaugh, G. Gordon, L. Noe, D. Bloedow, Smith Christopher, Dennis Brannon, R. Kush, D. Ng, E. Moore, Karen Bazemore, M. Galvan, D. Wagner, F. Harrell, D. Stablein
9 1994
9
🐜
🐒 Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
22 auth. Winfred C. Wang, R. Ware, Scott T. Miller, R. Iyer, J. Casella, C. Minniti, S. Rana, C. Thornburg, Z. Rogers, R. Kalpatthi, ... J. Barredo, R. C. Brown, S. Sarnaik, T. Howard, L. Wynn, A. Kutlar, F. D. Armstrong, B. Files, J. Goldsmith, M. Waclawiw, Xiangke Huang, B. Thompson
9 2011
9
🐒
🐜 Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.
7 auth. M. Egorin, D. A. Echo, S. Tipping, E. A. Olman, M. Whitacre, B. Thompson, ... J. Aisner
8 1984
8
🐜
🐜 Impact of hydroxyurea on clinical events in the BABY HUG trial.
12 auth. C. Thornburg, B. Files, Zhaoyu Luo, Scott T. Miller, R. Kalpatthi, R. Iyer, ... Phillip Seaman, J. Lebensburger, Ofelia A Alvarez, B. Thompson, R. Ware, Winfred C. Wang
7 2012
7
🐜
🐜 Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial.
13 auth. Z. Rogers, Winfred C. Wang, Zhaoyu Luo, R. Iyer, E. Shalaby-Rana, Stephen D. Dertinger, B. Shulkin, John H. Miller, B. Files, P. Lane, ... B. Thompson, Scott T. Miller, R. Ware
6 2011
6
🐜
🐜 Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma
19 auth. D. Green, M. Pont, Blythe Sather, A. Cowan, C. Turtle, B. Till, Anne M Nagengast, E. Libby, P. Becker, D. Coffey, ... S. Tuazon, B. Wood, M. Blake, Melissa G. Works, B. Thompson, T. Gooley, F. Appelbaum, D. Maloney, S. Riddell
6 2018
6
🐜
🐜 Effect of hydroxyurea treatment on renal function parameters: Results from the multi‐center placebo‐controlled BABY HUG clinical trial for infants with sickle cell anemia
14 auth. Ofelia A Alvarez, Scott T. Miller, Winfred C. Wang, Zhaoyu Luo, M. B. McCarville, George J. Schwartz, B. Thompson, T. Howard, R. Iyer, S. Rana, ... Z. Rogers, S. Sarnaik, C. Thornburg, R. Ware
6 2012
6
🐜
🐜 Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes
8 auth. V. Sheehan, Zhaoyu Luo, Jonathan M. Flanagan, T. Howard, B. Thompson, Winfred C. Wang, ... A. Kutlar, R. Ware
6 2013
6
🐜
🐜 Hydroxyurea Is Associated With Lower Costs of Care of Young Children With Sickle Cell Anemia
9 auth. Winfred C. Wang, S. Oyeku, Zhaoyu Luo, S. Boulet, Scott T. Miller, J. Casella, ... Billie Fish, B. Thompson, S. Grosse
6 2013
6
🐜
🦁 The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design
18 auth. B. Thompson, Scott T. Miller, Z. Rogers, R. C. Rees, R. Ware, M. Waclawiw, R. Iyer, J. Casella, L. Luchtman-Jones, S. Rana, ... C. Thornburg, R. Kalpatthi, J. Barredo, R. Brown, S. Sarnaik, T. Howard, L. Luck, Winfred C. Wang
6 2010
6
🦁
🐜 A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
10 auth. C. D. de Jongh, J. Joshi, B. Thompson, K. Newman, R. Finley, M. Moody, ... P. Salvatore, J. Tenney, G. Drusano, S. Schimpff
5 1986
5
🐜